News
-
08.17.2023Best Lawyers® 2024 Recognizes 388 Perkins Coie LawyersPress ReleasesPerkins Coie is proud to announce that 388 of its lawyers have been recognized by Best Lawyers® 2024. A total of 275 attorneys were selected by their peers for inclusion in the 2024 edition of The Best Lawyers in America® and 113 attorneys were selected for inclusion in the 2024 edition of Best Lawyers: Ones to Watch.
-
06.27.2023IAM Patent 1000 Recognizes Perkins Coie and 51 Lawyers as Patent Leaders in U.S. and AsiaPress ReleasesPerkins Coie is pleased to announce that 51 of its intellectual property (IP) lawyers in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2023 IAM Patent 1000 list.
-
06.01.2023Perkins Coie Named Among Top Law Firms in 2023 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
12.01.2022Perkins Coie Strengthens National Patent Litigation Practice with Four Prominent PartnersPress ReleasesPerkins Coie announced today the addition of a prominent four-partner patent litigation group that further deepens the firm’s powerhouse capabilities for technology sector clients in California and nationally. Partners Stefani Shanberg, Nathan Sabri, Veronica Ascarrunz, and Robin Brewer have all joined Perkins Coie’s internationally recognized Intellectual Property (IP) litigation practice.
-
08.18.2022Best Lawyers® 2023 Recognizes 403 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 403 of its attorneys have been recognized by Best Lawyers® 2023. A total of 279 attorneys were selected by their peers for inclusion in the 2023 edition of The Best Lawyers in America® and 124 attorneys were selected for inclusion in the 2023 edition of Best Lawyers: Ones to Watch.
-
8.10.2022IAM Patent 1000 Recognizes Perkins Coie and 49 Firm Attorneys as Patent Leaders in U.S. and ChinaPress ReleasesPerkins Coie is pleased to announce that 49 of its intellectual property (IP) attorneys in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2022 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation. The firm was also ranked nationally in the United States and China and internationally overall for patent litigation, prosecution, and post-grant proceedings.
-
07.06.2022Perkins Coie Recognized as IP and Life Sciences Leader in US and China by Managing IPPress ReleasesPerkins Coie is pleased to announce that it has again been ranked nationally in Managing Intellectual Property’s IP Stars guide, achieving recognition in five categories in 2022: Patent Contentious, Patent Prosecution, PTAB Litigation, Trademark Prosecution, and Life Sciences.
-
06.01.2022Perkins Coie Named Among Top Law Firms in 2022 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
02.14.2022Perkins Coie Shortlisted by Managing IP for the Americas Awards 2022General NewsPerkins Coie has been shortlisted by Managing IP for the Americas Awards 2022 per the article, The Managing IP Americas Awards 2022: Shortlists Revealed.
-
08.26.2021Best Lawyers® 2022 Recognizes 367 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 367 of its attorneys were recognized by the 2022 Best Lawyers®. A total of 278 attorneys were selected by their peers for inclusion in the 2022 edition of The Best Lawyers in America® and 89 attorneys were selected for inclusion in the 2022 edition of Best Lawyers: Ones to Watch.
-
08.04.2021IAM Patent 1000 Recognizes Perkins Coie and 46 Firm Attorneys as Patent Leaders in US and ChinaPress ReleasesPerkins Coie is pleased to announce that 44 of its intellectual property (IP) attorneys were recognized by Intellectual Asset Management (IAM) in the 2021 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation.
-
07.15.2021Perkins Coie’s Shannon Bloodworth Recognized as 2021 Top Women Attorneys in IP by Managing IPPress ReleasesPerkins Coie is pleased to announce that partners Shannon Bloodworth has been recognized among the 2021 “Top 250 Women in IP” by Managing IP. Shannon has been featured in the annual industry ranking for several years.
-
06.22.2021Perkins Coie Recognized as National Patent, Trademark, and Life Sciences Leader by Managing IPPress ReleasesPerkins Coie is pleased to announce that it has again been ranked nationally in Managing Intellectual Property’s IP Stars guide, achieving 2021 recognition in five categories: Patent Contentious, Patent Prosecution, PTAB Litigation, Trademark Prosecution, and Life Sciences.
-
05.20.2021Perkins Coie Named Among Top Law Firms in 2021 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States.
-
08.20.2020Best Lawyers® 2021 Recognizes 358 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 358 of its attorneys were recognized by Best Lawyers® 2021. A total of 290 attorneys were selected by their peers for inclusion in the 2021 edition of The Best Lawyers in America® and 68 attorneys were selected for inclusion in the inaugural edition of Best Lawyers: Ones to Watch.
-
07.02.2020Perkins Coie Recognized as National Patent and Life Sciences Leader by Managing IPPress ReleasesPerkins Coie is pleased to announce that it has again been ranked nationally in Managing Intellectual Property’s 2020 IP Stars guide in the Patent Contentious, Patent Prosecution, PTAB Litigation, and Life Sciences: IP categories.
-
06.30.2020IAM Patent 1000 Recognizes 37 Perkins Coie Attorneys as Top Practitioners and Names Perkins Coie a Patent Leader in US and ChinaPress ReleasesPerkins Coie is pleased to announce that the firm and 37 of its intellectual property attorneys were recognized by Intellectual Asset Management (IAM) in the 2020 IAM Patent 1000 list, which recognizes the world’s leading patent professionals who are the best-in-class in patent prosecution, licensing, and litigation.
-
04.27.2020Perkins Coie Named Among Top Law Firms in 2020 Chambers USAPress ReleasesPerkins Coie LLP is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States. For 2020, the firm is recognized for 55 practice areas and 141 individual attorneys, marking an increase from the 52 practices areas and 139 recognized attorneys a year ago.
-
02.05.2020Perkins Coie Shortlisted by Managing IP for the Americas Awards 2020General NewsPerkins Coie has been shortlisted by Managing IP for the Americas Awards 2020 per the article, "Managing IP Americas Awards 2020 Shortlists Announced."
-
01.17.2020Law360 Names Perkins Coie an IP Group of the YearPress ReleasesPerkins Coie is pleased to announce that its Intellectual Property practice has been recognized as a 2019 Practice Group of the Year by Law360. In its annual assessment of leading law firm practice groups, Law360 recognizes the firms that won significant litigation victories and managed large deals.
-
01.17.2020Perkins Coie Named an Intellectual Property Group of the Year by Law360General News
Law360
Perkins Coie has earned a spot among Law360's 2019 Intellectual Property Group of the Year. -
11.19.2019Perkins Coie’s Shannon Bloodworth Named a Law360 MVP of the Year in Intellectual PropertyPress ReleasesPerkins Coie is pleased to announce that Shannon Bloodworth, partner and co-chair of the firm’s Intellectual Property practice, has been recognized by Law360 as an MVP of the Year for her counsel and work in intellectual property litigation.
-
09.24.2019Perkins Coie Honored with Case of the Year and Top Litigator Awards by LMG Life SciencesPress ReleasesPerkins Coie is pleased to announce that the firm, Intellectual Property Co-Chair Shannon Bloodworth and Intellectual Property Partner David Anstaett have been recognized for their work in the life sciences industry by the LMG Life Sciences Awards, an annual ranking of leading North American law firms and lawyers specializing in the industry.
-
08.15.2019Best Lawyers® 2020 Recognizes 283 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 282 of its attorneys were selected by their peers for inclusion in the 2020 edition of The Best Lawyers in America®.
-
06.21.2019IAM Recognizes 33 Perkins Coie Attorneys as Top IP Practitioners and Names Firm a U.S. Litigation LeaderPress ReleasesPerkins Coie is pleased to announce that the firm and 33 of its intellectual property attorneys were recognized by Intellectual Asset Management in the IAM Patent 1000 list for 2019, which recognizes the world’s leading patent professionals who are the best in class in patent prosecution, licensing and litigation.
-
06.18.2019Managing Intellectual Property Recognizes 26 Perkins Coie Attorneys as IP Stars and Two as Top 250 Women in IPPress ReleasesPerkins Coie is pleased to announce that the firm and 26 of its intellectual property attorneys were recognized in Managing Intellectual Property’s (MIP) 2019 IP Stars list. Additionally, two women partners, Shannon Bloodworth, Firmwide Co-Chair of the Intellectual Property practice, and Grace Han Stanton again landed on the MIP Top 250 Women in IP list.
-
05.15.2019Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Kills 2 Patents on Horizon Pain Drug VimovoGeneral News
Law360
Andrew Dufresne, Autumn Nero, Dan Bagatell and Shannon Bloodworth were mentioned in the Law360 article, "Fed. Circ. Kills 2 Patents on Horizon Pain Drug Vimovo," as representation for Mylan when the U.S. Court of Appeals for the Federal Circuit ruled that two patents on Horizon Pharma's Vimovo are invalid. -
05.01.2019Perkins Coie Named Among Top Law Firms in 2019 Chambers USAPress ReleasesPerkins Coie is proud to announce that it has again been ranked by Chambers & Partners, publishers of Chambers USA: America’s Leading Lawyers for Business, as one of the top law firms in the United States. For 2019, the firm is recognized in 52 practice areas and 139 individual attorneys.
-
04.10.2019Perkins Coie Awarded Managing IP Patent Impact Case and Washington, D.C. IP Litigator of the YearPress ReleasesPerkins Coie is pleased to announce that it was named as having a patent impact case of the year by Managing IP’s Americas Awards for the successful representation of Mylan in its industry-shaping win in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals Inc., which convinced the U.S. Court of Appeals for the Federal Circuit that Indian tribal sovereign immunity cannot block the Patent Trial and Appeal Board (PTAB) from undertaking inter partes reviews (IPRs).
-
03.28.2019Perkins Coie Recognized for Top Performance in Federal Circuit Patent Appeals for Third Consecutive YearPress ReleasesPerkins Coie is pleased to announce that it has been recognized by Law360 as one of the firms that “crushed it” in patent cases decided by the Federal Circuit in 2018.
-
11.06.2018Perkins Coie Recognized as Leader for Gender Diversity Within IP Practice by ChIPsPress ReleasesPerkins Coie was recently named to the Honor Roll of the inaugural Inclusion Blueprint Survey, a joint initiative between ChIPs, a nonprofit organization focused on advancing women in technology, law and policy, and diversity and inclusion incubator, Diversity Lab.
-
10.29.2018Perkins Coie Attorneys Mentioned in Law360 - NJ Judge Invalidates Patent for Janssen Cancer Drug ZytigaGeneral NewsShannon M. Bloodworth, Brandon M. White, Maria A. Stubbings and Bryan D. Beel were mentioned as counsel for Mylan in the Law360* article, "NJ Judge Invalidates Patent for Janssen Cancer Drug Zytiga," regarding the invalidation of a patent that covered Janssen Biotech Inc.’s oncology medication, Zytiga.
*Subscription-based publication -
10.18.2018Perkins Coie Attorneys Mentioned in Law360 - Bristol-Myers, Pfizer's Blood Thinner IP Suit Axed Over VenueGeneral NewsShannon Bloodworth and Brandon White were mentioned as counsel for Mylan Pharmaceuticals Inc. in the Law360* article, "Bristol-Myers, Pfizer's Blood Thinner IP Suit Axed Over Venue," regarding the case against them getting thrown out due to being filed in the wrong venue.
*Subscription-based publication -
10.12.2018Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Rules Teva's Copaxone Patents Are InvalidGeneral NewsDavid Anstaett, Shannon Bloodworth, Brandon White, Dan Bagatell, and Christina Jordan McCullough were mentioned in the Law360* article, "Fed. Circ. Rules Teva's Copaxone Patents Are Invalid," as representation for Mylan Pharmaceuticals Inc. Bloomberg also covered the decision in the article, "Teva Loses Appeal Over Four Patents for MS Drug Copaxone."
*Subscription-based publication -
10.12.2018Perkins Coie Client Win Reported by Mylan - Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate CourtGeneral NewsPerkins Coie represented Mylan in its recent milestone Federal Circuit wins, relating to Glatiramer Acetate Injection 40mg/mL. The decision was reported in the Mylan article, "Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court."
-
05.15.2018Perkins Coie Announces Life Sciences Blog: 1600 PTAB & BeyondPress ReleasesPerkins Coie is proud to announce the launch of 1600 PTAB & Beyond, a blog that reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts.
-
04.24.2018Perkins Coie Attorneys Noted as Counsel in the Law.com Article - Skilled in the Art: Forget Oil States. It's Time to Get SAS-syGeneral News
Law.com
Perkins Coie was noted as counsel in the Law.com article, "Skilled in the Art: Forget Oil States. It's Time to Get SAS-sy," which discusses a slew of pharma companies challenging dosing patents. -
04.20.2018Perkins Coie Attorneys Noted as Counsel in the Law.com Article - Skilled in the Art: The Brave New World of Section 101 GuidanceGeneral News
Law.com
Perkins Coie was noted as counsel to Mylan, Teva and Akorn in the Law.com article, "Skilled in the Art: The Brave New World of Section 101 Guidance," which discusses whether Native American tribal immunity protects patents from inter partes review. -
04.19.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.General News
Law360
Perkins Coie attorney Brandon White was noted as counsel to Mylan in the Law360 article, “Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.,” regarding The Patent Trial and Appeal Board going against decades of U.S. Supreme Court precedent. -
04.02.2018Perkins Coie Names Diverse Partners to Leadership PositionsPress ReleasesPerkins Coie is pleased to announce that it has appointed numerous diverse partners to leadership positions, including women and partners of color.
-
03.26.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRsGeneral News
Law360
Perkins Coie attorneys Eric Miller, Charles Curtis, Andrew Dufresne, Shannon Bloodworth, Brandon White and Dan Bagatell were noted as counsel to Mylan in the Law360 article, "Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs," regarding the Patent Trial and Appeal Board's review of patents. -
03.19.2018Perkins Coie Team Mentioned in Law360 - Tribe Asks Fed. Circ. To Pause Restasis Patent ReviewsGeneral News
Law360
The Perkins Coie team representing Mylan was mentioned in the Law360 article, “Tribe Asks Fed. Circ. To Pause Restasis Patent Reviews,” regarding the Federal Circuit being asked to stop the Patent Trial and Appeal Board’s review of certain patents. -
02.23.2018Perkins Coie Attorneys Recognized as Mylan Pharmaceuticals Representation in Law360 Article - Tribe Not Immune From Restasis IP Challenges, PTAB SaysGeneral News
Law360
Perkins Coie attorneys recognized as Mylan Pharmaceutical's representation in Law360 article, "Tribe Not Immune From Restasis IP Challenges, PTAB Says." -
02.21.2018Perkins Coie Again Recognized for Top Performance in Patent AppealsPress ReleasesPerkins Coie is pleased to announce that the firm has been recognized by Law360 as one of the firms that “dominated” in patent cases decided by the Federal Circuit in 2017 due to its 8–1 win–loss record. Perkins Coie tied for fifth in total victories, and the firm’s record tied for second-best of all listed firms. This is the second year in a row that Perkins Coie has been ranked in the top eight for overall case wins.
-
02.19.2018Perkins Coie Featured in Law360 - The Firms That Dominated At The Federal Circuit In 2017General NewsPerkins Coie was featured in the Law360 article, “The Firms That Dominated At The Federal Circuit In 2017.” The article noted Perkins Coie’s 8–1 record in patent cases in the Federal Circuit during 2017. Perkins Coie tied for fifth in total victories, and its won–loss record tied for second-best of all listed firms.
-
02.08.2018Perkins Coie Recognized As a Top Three Patent Litigation Defense Firm Second Year in a RowPress ReleasesPerkins Coie is pleased to announce that the firm has been recognized as one of the top three patent litigation defense law firms in the nation by Lex Machina in its fourth annual Patent Litigation Year in Review report. Of the national law firms handling the most patent cases in 2017, Perkins Coie ranked third with 56 of those cases. This is the second year in a row Perkins Coie has been in the top three.
-
01.04.2018Steve Bishop and Shannon Bloodworth Named Firmwide Co-Chairs of Perkins Coie’s Intellectual Property PracticePress ReleasesPerkins Coie is pleased to announce that Steve Bishop and Shannon Bloodworth have been named Firmwide Co-Chairs of the firm’s Intellectual Property practice. Steve, a partner in the firm’s Seattle office, and Shannon, a partner in its Washington, D.C. office, succeed former Co-Chairs Paul Parker and Jon James.
-
04.13.2017Several Perkins Coie Attorneys Mentioned in Law360's Weekly Verdict: Legal Lions & LambsGeneral News
Law360
Several Perkins Coie attorneys were mentioned in the article "Law360's Weekly Verdict: Legal Lions & Lambs," published by Law360. -
12.22.2015Shannon Bloodworth Quoted in Law360 - How Great Lawyers Win Bad CasesGeneral News
Law360
Shannon Bloodworth was quoted in "How Great Lawyers Win Bad Cases," in Law360 regarding understanding the strengths and weaknesses in cases.
-
11.13.2015Shannon Bloodworth Mentioned as a Law360's Intellectual Property MVPsGeneral News
Law360
Shannon Bloodworth is listed on the list of Law360's Intellectual Property MVPs. -
06.22.201530 Perkins Coie Attorneys Recognized by Intellectual Asset Management Magazine as Top Patent Practitioners; Two As World’s Leading IP StrategistsPress ReleasesPerkins Coie is pleased to announce that 30 of the firm’s intellectual property attorneys were recognized by Intellectual Asset Management (IAM) in the IAM Strategy 300 and IAM Patent 1000 lists.
-
06.17.201427 Perkins Coie Attorneys Recognized by Intellectual Asset Management Magazine as Top Patent PractitionersPress ReleasesPerkins Coie is pleased to announce that 27 of the firm’s intellectual property attorneys were recognized by Intellectual Asset Management (IAM) in the IAM Patent 1000 and IAM Strategy 300 lists. The lists, published in the June 2014 issue of IAM Magazine, provide in-house counsel with detailed information on top patent practitioners in many major jurisdictions worldwide.